Brokerages Set .00 Target Price for Acura Pharmaceuticals, Inc. (NASDAQ:ACUR)
Acura Pharmaceuticals logo Shares of Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) have received an average broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports.
Read more on Zolmax
New Honda Ridgeline, Acura concept to debut in Detroit
Inc. said Friday it will reveal its new 2017 Honda Ridgeline midsize pickup and the Acura Precision Concept next month at the 2016 North American International Auto Show in Detroit. The Japanese automaker said the Ridgeline will be revealed at 1:15 p.m …
Read more on The Detroit News